Dany Anglicheau
Overview
Explore the profile of Dany Anglicheau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
225
Citations
4244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noble J, Anglicheau D, Blancho G, Bertrand D, Couzi L, Durrbach A, et al.
Nephrol Ther
. 2025 Mar;
21(1):37-47.
PMID: 40066607
The standard immunosuppressive treatment after organ transplantation typically includes a calcineurin inhibitor (tacrolimus or cyclosporine A), an antimetabolite (mycophenolic acid) or an mTOR inhibitor, and corticosteroids. However, these treatments are...
2.
Benotmane I, Kasriel N, Masset C, Michard B, Malvezzi P, Giguet B, et al.
Transplantation
. 2025 Jan;
PMID: 39883018
Background: It remains unclear whether physicians should accept transplantation offers for candidates with a positive SARS-CoV-2 reverse transcription polymerase chain reaction test due to the potential risk of severe infection...
3.
Bodard S, Denis L, Chabouh G, Anglicheau D, Helenon O, Correas J, et al.
Theranostics
. 2025 Jan;
15(1):233-244.
PMID: 39744234
Renal pseudotumors, which mimic tumors on imaging, pose diagnostic challenges that can lead to unnecessary interventions. Sensing ultrasound localization microscopy (sULM) is an advanced imaging technique that uses ultrasound imaging...
4.
Terinte-Balcan G, Lebraud E, Zuber J, Anglicheau D, Ismail G, Rabant M
Transpl Int
. 2024 Dec;
37:13835.
PMID: 39722854
While the Banff classification dichotomizes kidney allograft rejection based on the localization of the cells in the different compartments of the cortical kidney tissue [schematically interstitium for T cell mediated...
5.
Bertrand D, Chavarot N, Olagne J, Greze C, Gatault P, Danthu C, et al.
Transpl Int
. 2024 Dec;
37:13544.
PMID: 39712083
After kidney transplantation, conversion to belatacept is a promising alternative in patients with poor graft function or intolerance to calcineurin inhibitors. The risk of acute rejection has not been well...
6.
Arches C, Usureau C, Anglicheau D, Hertig A, Jalal-Eddine A, Zaidan M, et al.
Transpl Int
. 2024 Dec;
37:13639.
PMID: 39679067
Kidney retransplantations are associated with an increased risk of rejection and reduced graft survival compared to first transplantations, notably due to HLA sensitization. The impact of repeated eplet mismatches on...
7.
Caillard S, Meyer N, Solis M, Bertrand D, Jaureguy M, Anglicheau D, et al.
Kidney Int
. 2024 Nov;
107(2):338-347.
PMID: 39490986
The MTOR inhibitors have demonstrated antiviral properties, and prior non-randomized studies have suggested they may have a suppressive effect on BKPyV replication. Here, in this randomized, multicenter, controlled trial (BKEVER...
8.
Marquet P, Anglicheau D, Humeau A, Adrouche S, Saada L, Bisiaux J, et al.
Transpl Int
. 2024 Oct;
37:13495.
PMID: 39469664
All the factors potentially influencing tacrolimus dose requirement and combinations thereof have never been thoroughly investigated, precluding accurate prediction of tacrolimus starting dose. This prospective, non-interventional, multicenter study in adult...
9.
Van Loon E, Lamarthee B, Callemeyn J, Farhat I, Koshy P, Anglicheau D, et al.
Am J Transplant
. 2024 Oct;
25(3):531-544.
PMID: 39461479
Contrary to immune cells, the response of the kidney structural cells in rejection is less established. We performed single-cell RNA sequencing of 18 kidney transplant biopsies from 14 recipients. Single-cell...
10.
Sablik M, Sannier A, Raynaud M, Goutaudier V, Divard G, Astor B, et al.
N Engl J Med
. 2024 Oct;
392(8):763-776.
PMID: 39450752
Background: The heterogeneous clinical presentation of graft microvascular inflammation poses a major challenge to successful kidney transplantation. The effect of microvascular inflammation on allograft outcomes is unclear. Methods: We conducted...